EFFECTS OF ISOMERS OF HYDROXYAPORPHINES ON DOPAMINE METABOLISM IN RAT-BRAIN REGIONS

被引:16
作者
BALDESSARINI, RJ
MARSH, ER
KULA, NS
ZONG, RS
GAO, YG
NEUMEYER, JL
机构
[1] HARVARD UNIV,SCH MED,DEPT PSYCHIAT,BOSTON,MA 02115
[2] HARVARD UNIV,SCH MED,NEUROSCI PROGRAM,BOSTON,MA 02115
[3] NORTHEASTERN UNIV,COLL PHARM & ALLIED HLTH PROFESS,MED CHEM SECT,BOSTON,MA 02115
[4] MASSACHUSETTS GEN HOSP,MCLEAN DIV,MAILMAN RES CTR,PSYCHIAT RES LABS,BELMONT,MA 02178
关键词
D O I
10.1016/0006-2952(90)90538-V
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effects of isomers of di- and monohydroxyaporphines on cerebral dopamine (DA) metabolism were evaluated in representative extrapyramidal (corpus striatum) and limbic (nucleus accumbens septi) tissues of rat brain by three methods: (1) changes in the ratio of homovanillic acid (HVA) to DA, (2) accumulation of l-dihydroxyphenylalanine (DOPA) after inhibiting its decarboxylation to DA under "open-loop" conditions, as well as (3) after γ-butyrolactone (GBL) pretreatment to provide selective effects at presynaptic DA autoreceptors. The DA-agonist R(-) isomers of the aporphines apomorphine (APO), N-n-propylnorapomorphine (NPA), and 11-hydroxy-N-n-propyl-noraporphine (11-OH-NPa) showed consistent dose-dependent inhibition of DA synthesis in both brain regions with all models; the neuroleptic haloperidol had the opposite effect in the first two models only, as expected. The S(+) isomers of NPA and 11-OH-NPa have shown behavioral evidence of antidopaminergic activity, especially in the limbic system. Unlike the neuroleptic, 5(+)NPA did not show DA-synthesis enhancing actions in accumbens or striatal tissue but, instead, inhibited DA synthesis like its R(-) antipode in all three test paradigms. S(+)11-OH-NPa given alone produced minor changes in the HVA/DA ratio and did not antagonize R(-)11-OH-NPa, weakly increased accumulation of DOPA in the second model, and had no effect in the third-all without regional selectivity. In the test of autoreceptor functioning, the dihydroxyaporphine S(+)NPA, but not S(+)11-OH-NPa, inhibited DA synthesis and this effect, in turn, was largely reversed by haloperidol, as were the inhibitory effects of the three R(-)aporphines tested. In this model, however, neither S(+)NPA nor S(+)11-OH-NPa antagonized the DA-synthesis inhibiting effect of R(-)APO as haloperidol did. Overall, these results are consistent with evidence that R(-)NPA and 11-OH-NPa have high affinity at D-2 receptor sites in rat brain and show behavioral effects of typical DA agonists. The non-stereoselective inhibitory effects of NPA on DA synthesis may reflect its activity as a weak DA agonist with very low intrinsic activity, but may also include a direct "catechol-effect" on tyrosine hydroxylase. In contrast, R(-)11-OH-NPa appears to be a stereoselective D-2 agonist, active at autoreceptors as well as postsynaptic receptors, that lacks the nonstereospecific effects on DA metabolism of its catechol-aporphine congener. It may be a useful probe for the further characterization of dopamine receptors and autoreceptors. © 1990.
引用
收藏
页码:417 / 423
页数:7
相关论文
共 25 条
[1]   SYNTHETIC ANALGESICS AND OTHER PHENYLPIPERIDINES - EFFECTS ON UPTAKE AND STORAGE OF DOPAMINE AND OTHER MONOAMINES MOUSE FOREBRAIN TISSUE [J].
BALDESSARINI, RJ ;
KULA, NS ;
FRANCOEUR, D ;
FINKLESTEIN, SP ;
MURPHY, F ;
NEUMEYER, JL .
LIFE SCIENCES, 1986, 39 (19) :1765-1777
[2]  
BOOTH R G, 1989, Society for Neuroscience Abstracts, V15, P427
[3]  
BRAUTIGAM M, 1985, MOL PHARMACOL, V28, P515
[4]   S(+)APOMORPHINES - SELECTIVE-INHIBITION OF EXCITATORY EFFECTS OF DOPAMINE INJECTED INTO THE LIMBIC SYSTEM OF THE RAT [J].
CAMPBELL, A ;
BALDESSARINI, RJ ;
TEICHER, MH ;
NEUMEYER, JL .
NEUROPHARMACOLOGY, 1985, 24 (05) :391-399
[5]   BEHAVIORAL-EFFECTS OF APOMORPHINE ISOMERS IN THE RAT - SELECTIVE LOCOMOTOR-INHIBITORY EFFECTS OF S(+)N-N-PROPYLNORAPOMORPHINE [J].
CAMPBELL, A ;
BALDESSARINI, RJ ;
TEICHER, MH ;
NEUMEYER, JL .
PSYCHOPHARMACOLOGY, 1986, 88 (02) :158-164
[6]   BROMOCRIPTINE ANTAGONIZES BEHAVIORAL-EFFECTS OF COCAINE IN THE RAT [J].
CAMPBELL, A ;
BALDESSARINI, RJ ;
CREMENS, C ;
TEICHER, MH ;
MARSH, E ;
KULA, NS .
NEUROPSYCHOPHARMACOLOGY, 1989, 2 (03) :209-224
[7]  
CAMPBELL A, IN PRESS NEUROPHARMA
[8]  
COX RF, 1988, J PHARMACOL EXP THER, V247, P355
[9]  
COX RF, 1989, MOL PHARMACOL, V34, P125
[10]   CHANGES IN CORTICAL AND SUBCORTICAL LEVELS OF MONOAMINES AND THEIR METABOLITES FOLLOWING UNILATERAL VENTROLATERAL CORTICAL-LESIONS IN THE RAT [J].
FINKLESTEIN, S ;
CAMPBELL, A ;
STOLL, AL ;
BALDESSARINI, RJ ;
STINUS, L ;
PASKEVITCH, PA ;
DOMESICK, VB .
BRAIN RESEARCH, 1983, 271 (02) :279-288